BidaskClub lowered shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from a buy rating to a hold rating in a research note issued to investors on Monday, July 31st.
Other research analysts have also issued reports about the company. Deutsche Bank AG started coverage on Acadia Healthcare in a research report on Wednesday, April 5th. They issued a buy rating and a $53.00 target price on the stock. Mizuho increased their price objective on Acadia Healthcare from $57.00 to $60.00 and gave the company a buy rating in a report on Friday, July 28th. Zacks Investment Research raised Acadia Healthcare from a hold rating to a buy rating and set a $53.00 price objective on the stock in a report on Wednesday, June 28th. Jefferies Group LLC set a $55.00 price objective on Acadia Healthcare and gave the company a buy rating in a report on Thursday, June 1st. Finally, Craig Hallum reissued a buy rating and set a $65.00 price objective (up previously from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Five analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $59.21.
Shares of Acadia Healthcare (ACHC) traded up 2.77% during mid-day trading on Monday, hitting $52.38. The stock had a trading volume of 1,219,461 shares. The firm has a market cap of $4.60 billion, a price-to-earnings ratio of 575.60 and a beta of 1.15. Acadia Healthcare has a one year low of $32.54 and a one year high of $54.73. The company has a 50-day moving average of $50.30 and a 200 day moving average of $44.67.
Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. During the same period in the prior year, the firm posted $0.73 EPS. The business’s revenue was down 5.4% compared to the same quarter last year. On average, equities research analysts forecast that Acadia Healthcare will post $2.45 earnings per share for the current year.
In other Acadia Healthcare news, EVP Christopher L. Howard sold 16,762 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $52.47, for a total value of $879,502.14. Following the completion of the sale, the executive vice president now owns 200,999 shares in the company, valued at approximately $10,546,417.53. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Reeve B. Waud sold 1,240,000 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $51.72, for a total value of $64,132,800.00. The disclosure for this sale can be found here. Insiders sold a total of 2,136,347 shares of company stock worth $105,383,249 in the last ninety days. Insiders own 11.10% of the company’s stock.
Hedge funds have recently made changes to their positions in the company. BlackRock Inc. increased its stake in shares of Acadia Healthcare by 65.6% in the second quarter. BlackRock Inc. now owns 8,523,077 shares of the company’s stock worth $420,871,000 after buying an additional 3,377,291 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Acadia Healthcare by 0.8% in the first quarter. JPMorgan Chase & Co. now owns 7,705,975 shares of the company’s stock worth $335,980,000 after buying an additional 59,735 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 8.9% in the second quarter. Vanguard Group Inc. now owns 6,254,532 shares of the company’s stock worth $308,849,000 after buying an additional 511,299 shares in the last quarter. Aristotle Capital Management LLC purchased a new stake in shares of Acadia Healthcare during the first quarter worth approximately $140,071,000. Finally, FMR LLC increased its stake in shares of Acadia Healthcare by 26.4% in the second quarter. FMR LLC now owns 2,775,451 shares of the company’s stock worth $137,052,000 after buying an additional 580,449 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.